Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
AbstractCholangiocarcinoma (CCA) is a highly-aggressive malignancy arising from the biliary tree, characterized by a steady increase in incidence globally and a high mortality rate. Most CCAs are diagnosed in the advanced and metastatic phases of the disease, due to the paucity of signs and symptoms in the early stages. This fact, along with the poor results of the local and systemic therapies currently employed, is responsible for the poor outcome of CCA patients and strongly supports the need for novel therapeutic agents and strategies. In recent years, the introduction of next-generation sequencing technologies has opened new horizons for a better understanding of the genetic pathophysiology of CCA and, consequently, for the identification and evaluation of new treatments tailored to the molecular features or alterations progressively elucidated. In this review article, we describe the potential targets under investigation and the current molecular therapies employed in biliary tract cancers. In addition, we summarize the main drugs against CCA under evaluation in ongoing trials and describe the preliminary data coming from these pioneering studies. View Full-Text
Share & Cite This Article
Simile, M.M.; Bagella, P.; Vidili, G.; Spanu, A.; Manetti, R.; Seddaiu, M.A.; Babudieri, S.; Madeddu, G.; Serra, P.A.; Altana, M.; Paliogiannis, P. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials. Medicina 2019, 55, 42.
Simile MM, Bagella P, Vidili G, Spanu A, Manetti R, Seddaiu MA, Babudieri S, Madeddu G, Serra PA, Altana M, Paliogiannis P. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials. Medicina. 2019; 55(2):42.Chicago/Turabian Style
Simile, Maria M.; Bagella, Paola; Vidili, Gianpaolo; Spanu, Angela; Manetti, Roberto; Seddaiu, Maria A.; Babudieri, Sergio; Madeddu, Giordano; Serra, Pier A.; Altana, Matteo; Paliogiannis, Panagiotis. 2019. "Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials." Medicina 55, no. 2: 42.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.